Ashish Verma, MD

Assistant Professor, Boston University Chobanian & Avedisian School of Medicine

Biography

Dr. Verma is a clinician-investigator interested in chronic kidney disease (CKD), renal amyloidosis, cardiorenal syndrome, diabetic kidney disease (DKD), renal physiology, and electrolyte abnormalities. Dr. Verma's research projects include epidemiologic investigations utilizing large databases and translational and patient-oriented research projects. Ongoing studies include predictors of CKD progression using CRIC cohort and UK biobank, predictors of mortality using NHANES, a Physiology study examining the role of Kidney Function Reserve and renal plasma flow in phenotyping chronic kidney disease, and the role of intravitreal VEGF inhibitors in causing nephrotoxicity, and renal physiology of decongestion in patients with Acute decompensated heart failure(ADHF). Dr. Verma is a member of the APRC committee for the Framingham Heart Study, the Renal subgroup for clinical endpoints in Amyloidosis for the Amyloidosis research consortium, and the Membership Committee for Kidney in Cardiovascular Medicine for the American Heart Association. He is on the Editorial Board of Therapeutic Advances in Endocrinology and Metabolism, Therapeutic Advances in Chronic Disease, Plos One, and BMC Medicine.

Publications

  • Published 7/29/2025

    Wittig M, Verma A, Bellavia A, Rosan S, Claudel SE, Surapaneni A, Palsson R, Srivastava A, Stillman IE, Henderson JM, Beck LH, Hodgin JB, Grams ME, Rhee EP, Huber TB, Waikar SS, Schmidt IM. The Associations of Foot Process Effacement with Kidney Histopathologic Lesions and Disease Progression. Kidney360. 2025 Jul 29. PMID: 40728890.

    Read at: PubMed

  • Published 6/26/2025

    Aronov AG, Verma A, Ricardo AC, Kelly TN, Waikar SS, Lash JP, Srivastava A. Associations of Proteinuria Trajectories with Kidney Failure and Death in Individuals with CKD. Kidney360. 2025 Jun 26. PMID: 40569689.

    Read at: PubMed

  • Published 5/2/2025

    Claudel SE, Waikar SS, Verma A. Albuminuria References Ranges in Healthy US Adults. J Appl Lab Med. 2025 May 02; 10(3):767-771. PMID: 39981782.

    Read at: PubMed

  • Published 4/14/2025

    Solomon M, Claudel S, Verma A. Cardiovascular-Kidney-Metabolic Health: Definition, Staging, Risk Assessment, and Therapeutic Considerations. Cardiol Clin. 2025 Aug; 43(3):337-357. PMID: 40582729.

    Read at: PubMed

  • Published 4/1/2025

    Kar D, Byng R, Sheikh A, Nath M, Zabeen B, Kar S, Banu S, Sarker MHR, Khan N, Acharjee D, Islam S, Allgar V, Ordóñez-Mena JM, El-Wazir A, Song S, Verma A, Kadam U, de Lusignan S. Navigating the complexities of end-stage kidney disease (ESKD) from risk factors to outcome: insights from the UK Biobank cohort. BMC Nephrol. 2025 Apr 01; 26(1):168. PMID: 40169952.

    Read at: PubMed

View All 71 Publications:   View Full Profile in BUMC

Websites

Education

  • Stanley Medical School, MBBS

View all profiles